Thursday, 16 April, 2009 06:06 Written by admin
Scientists have found important genetic differences that significantly raise the risk of stroke, and they are found in millions of people.
The study is the first to identify common genetic variants influencing stroke risk in the United States and may lead to better treatments, they reported on Wednesday.
While other stroke-related genes have been discovered, none involved such a wide portion of the population, said Eric Boerwinkle of The University of Texas Health Science Center.
Thursday, 16 April, 2009 05:50 Written by admin
More than half of the newly diagnosed patients with type 1 diabetes who got an experimental treatment for the disease did not need insulin injections for at least a year.
Patients also showed improvements in the functioning of the insulin-producing cells that are attacked and destroyed in patients with type 1 diabetes.
Four of the 23 patients who took part in the study remained insulin free for at least three years and one patient went without insulin injections for more than four years.
Thursday, 11 December, 2008 22:11 Written by admin
Researchers continue to test the mettle of breakthrough breast cancer drugs, three decades after tamoxifen changed the medical landscape by drastically reducing the risk of recurrences in women with estrogen receptor-positive tumors.
Encouraging findings on several different drugs were presented Thursday at the CTRC-AACR San Antonio Breast Cancer Symposium in Texas.
Friday, 28 November, 2008 04:39 Written by admin
NEW YORK (Reuters Health) – Eating fish at least twice a week seems to reduce the incidence of kidney disease in patients with diabetes, according to findings from a large British study.
Although diabetics are advised to limit dietary protein to delay the progression of kidney disease, recent observations suggest that the benefit to the kidneys may have to do with “the protein source rather than quantity,” the investigators note in the American Journal of Kidney Diseases.
Despite research linking fish to improved outcomes in diabetics, they add, epidemiological evidence of this benefit is scarce.